Adriana Cabré

Adriana Cabré

Human Resources Officer at CRINETICS PHARMACEUTICALS, INC.

Health Technology
Consumer Services
Finance

Profile

Adriana Cabré is the founder of ACC People Strategies.
She is currently the Chief Human Resources Officer at Crinetics Pharmaceuticals, Inc. Ms. Cabré previously worked as the Senior Director & Vice President-Human Resources at Amylin Pharmaceuticals, Inc. from 2006 to 2014.
She also served as the Director-Human Resources at CooperVision, Inc. and Motorola Mobility LLC from 1992 to 2004.
From 2016 to 2019, Ms. Cabré held the position of Chief People Officer at National University.
Additionally, she was the Senior Vice President-Human Resources at MedImpact Healthcare Systems, Inc. from 2014 to 2016.
Ms. Cabré completed her undergraduate degree at Duquesne University of The Holy Spirit and earned an MBA from Nova Southeastern University, Inc.

Adriana Cabré active positions

CompaniesPositionStart
CRINETICS PHARMACEUTICALS, INC. Human Resources Officer 2020-05-26
All active positions of Adriana Cabré

Former positions of Adriana Cabré

CompaniesPositionEnd
National University Human Resources Officer 2019-08-31
Human Resources Officer 2016-04-30
Director/Board Member 2013-12-31
Human Resources Officer 2004-08-31
ACC People Strategies Founder -
See the detail of Adriana Cabré's experience

Training of Adriana Cabré

Duquesne University of The Holy Spirit Undergraduate Degree
Nova Southeastern University, Inc. Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adriana Cabré's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CRINETICS PHARMACEUTICALS, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Finance

Electronic Technology

ACC People Strategies

See company connections
  1. Stock Market
  2. Insiders
  3. Adriana Cabré
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW